OSVAREN

This brand name is authorized in Austria, Estonia, Spain, France, Lithuania, Netherlands, Romania, United Kingdom, South Africa

Active ingredients

The drug OSVAREN contains a combination of these active pharmaceutical ingredients (APIs):

1 Calcium acetate
UNII Y882YXF34X - CALCIUM ACETATE

Calcium is an endogenous ion of the body essential for the maintenance of a number of physiologic processes. It participates as an integral factor in the maintenance of the functional integrity of the nervous system, in the contractile mechanisms of muscle tissue, in the clotting of blood, and in the formation of the major structural material of the skeleton. Soluble calcium salts are commonly used in the treatment of calcium deficiency.

Read about Calcium acetate
2 Magnesium carbonate heavy
UNII 0E53J927NA - MAGNESIUM CARBONATE

Magnesium carbonate, MgCO3 (archaic name magnesia alba), is an inorganic salt. The most common magnesium carbonate forms are the anhydrous salt called magnesite (MgCO3) and the di, tri, and pentahydrates known as barringtonite (MgCO3·2 H2O), nesquehonite (MgCO3·3 H2O), and lansfordite (MgCO3·5 H2O), respectively. The primary use of magnesium carbonate is the production of magnesium oxide by calcining.

Read about Magnesium carbonate

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
OSVAREN Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V03AE04 Calcium acetate and magnesium carbonate V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1287592
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 69670
Country: FR Base de données publique des médicaments Identifier(s): 68613807
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 151790
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1028126, 1080796
Country: NL Z-Index G-Standaard, PRK Identifier(s): 98167
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W59601001
Country: ZA Health Products Regulatory Authority Identifier(s): 45/24/0919

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.